162 related articles for article (PubMed ID: 20032101)
1. CXCL 9 and CXCL 10 as Sensitive markers of disease activity in patients with rheumatoid arthritis.
Kuan WP; Tam LS; Wong CK; Ko FW; Li T; Zhu T; Li EK
J Rheumatol; 2010 Feb; 37(2):257-64. PubMed ID: 20032101
[TBL] [Abstract][Full Text] [Related]
2. CCL2, CXCL8, CXCL9 and CXCL10 serum levels increase with age but are not altered by treatment with hydroxychloroquine in patients with osteoarthritis of the knees.
Bonfante HL; Almeida CS; Abramo C; Grunewald STF; Levy RA; Teixeira HC
Int J Rheum Dis; 2017 Dec; 20(12):1958-1964. PubMed ID: 25955863
[TBL] [Abstract][Full Text] [Related]
3. [Effect of chemokines CXCL9 and CXCL10 on bone erosion in patients with rheumatoid arthritis].
Zhong H; Xu LL; Bai MX; Su Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 53(6):1026-1031. PubMed ID: 34916676
[TBL] [Abstract][Full Text] [Related]
4. Chemokine levels predict progressive liver disease in Down syndrome patients with transient abnormal myelopoiesis.
Kinjo T; Inoue H; Kusuda T; Fujiyoshi J; Ochiai M; Takahata Y; Honjo S; Koga Y; Hara T; Ohga S
Pediatr Neonatol; 2019 Aug; 60(4):382-388. PubMed ID: 30314728
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum levels of CXCL9/monokine induced by interferon-gamma and CXCL10/interferon-gamma-inducible protein-10 in ocular sarcoidosis.
Takeuchi M; Oh-I K; Suzuki J; Hattori T; Takeuchi A; Okunuki Y; Usui Y; Usui M
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1063-8. PubMed ID: 16505042
[TBL] [Abstract][Full Text] [Related]
6. Blood chemokine profile in untreated early rheumatoid arthritis: CXCL10 as a disease activity marker.
Pandya JM; Lundell AC; Andersson K; Nordström I; Theander E; Rudin A
Arthritis Res Ther; 2017 Feb; 19(1):20. PubMed ID: 28148302
[TBL] [Abstract][Full Text] [Related]
7. Baseline CXCL10 and CXCL13 levels are predictive biomarkers for tumor necrosis factor inhibitor therapy in patients with moderate to severe rheumatoid arthritis: a pilot, prospective study.
Han BK; Kuzin I; Gaughan JP; Olsen NJ; Bottaro A
Arthritis Res Ther; 2016 Apr; 18():93. PubMed ID: 27102921
[TBL] [Abstract][Full Text] [Related]
8. Regulation of serum chemokines following infliximab therapy in patients with rheumatoid arthritis.
Klimiuk PA; Sierakowski S; Domyslawska I; Chwiecko J
Clin Exp Rheumatol; 2006; 24(5):529-33. PubMed ID: 17181921
[TBL] [Abstract][Full Text] [Related]
9. Chemokine signals are crucial for enhanced homing and differentiation of circulating osteoclast progenitor cells.
Sucur A; Jajic Z; Artukovic M; Matijasevic MI; Anic B; Flegar D; Markotic A; Kelava T; Ivcevic S; Kovacic N; Katavic V; Grcevic D
Arthritis Res Ther; 2017 Jun; 19(1):142. PubMed ID: 28619088
[TBL] [Abstract][Full Text] [Related]
10. Correlation of CX3CL1 and CX3CR1 levels with response to infliximab therapy in patients with rheumatoid arthritis.
Odai T; Matsunawa M; Takahashi R; Wakabayashi K; Isozaki T; Yajima N; Miwa Y; Kasama T
J Rheumatol; 2009 Jun; 36(6):1158-65. PubMed ID: 19369458
[TBL] [Abstract][Full Text] [Related]
11. Interferon-inducible chemokines reflect severity and progression in sarcoidosis.
Su R; Nguyen ML; Agarwal MR; Kirby C; Nguyen CP; Ramstein J; Darnell EP; Gomez AD; Ho M; Woodruff PG; Koth LL
Respir Res; 2013 Nov; 14(1):121. PubMed ID: 24199653
[TBL] [Abstract][Full Text] [Related]
12. Histological patterns of synovitis and serum chemokines in patients with rheumatoid arthritis.
Klimiuk PA; Sierakowski S; Latosiewicz R; Skowronski J; Cylwik JP; Cylwik B; Chwiecko J
J Rheumatol; 2005 Sep; 32(9):1666-72. PubMed ID: 16142858
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin does not reduce chemokine production in obesity without comorbidities.
Fernandes KS; Béla SR; Andrade VL; de Moraes TF; de Assis Martins-Filho O; Sandrim VC
Inflammation; 2015; 38(3):1297-301. PubMed ID: 25676434
[TBL] [Abstract][Full Text] [Related]
14. Chemokines as markers of local inflammation and angiogenesis in patients with chronic subdural hematoma: a prospective study.
Stanisic M; Lyngstadaas SP; Pripp AH; Aasen AO; Lindegaard KF; Ivanovic J; Ilstad E; Konglund A; Sandell T; Ellingsen O; Saehle T
Acta Neurochir (Wien); 2012 Jan; 154(1):113-20; discussion 120. PubMed ID: 22037980
[TBL] [Abstract][Full Text] [Related]
15. The changes in serum chemokines following leflunomide therapy in patients with rheumatoid arthritis.
Klimiuk PA; Kita J; Chwiecko J; Sierakowski S
Clin Rheumatol; 2009 Jan; 28(1):17-21. PubMed ID: 18663553
[TBL] [Abstract][Full Text] [Related]
16. [Serum levels of several chemokines in patients with rheumatoid arthritis].
Wu HX; Zhang Y; Zhu YL
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):534-7. PubMed ID: 15949333
[TBL] [Abstract][Full Text] [Related]
17. Relationship between serum RANTES levels and radiological progression in rheumatoid arthritis patients treated with methotrexate.
Boiardi L; Macchioni P; Meliconi R; Pulsatelli L; Facchini A; Salvarani C
Clin Exp Rheumatol; 1999; 17(4):419-25. PubMed ID: 10464551
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of serum levels of chemokines during interferon-β treatment in multiple sclerosis patients: a 1-year, observational cohort study.
Comini-Frota ER; Teixeira AL; Angelo JP; Andrade MV; Brum DG; Kaimen-Maciel DR; Foss NT; Donadi EA
CNS Drugs; 2011 Nov; 25(11):971-81. PubMed ID: 22054120
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers in Remission According to Different Criteria in Patients with Rheumatoid Arthritis.
Yilmaz-Oner S; Ozen G; Can M; Atagunduz P; Direskeneli H; Inanc N
J Rheumatol; 2015 Nov; 42(11):2066-70. PubMed ID: 26472417
[TBL] [Abstract][Full Text] [Related]
20. CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritis.
Sellam J; Rouanet S; Hendel-Chavez H; Miceli-Richard C; Combe B; Sibilia J; Le Loët X; Tebib J; Jourdan R; Dougados M; Taoufik Y; Mariette X
Arthritis Rheum; 2013 Sep; 65(9):2253-61. PubMed ID: 23740460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
